Cargando…
Pharmaceutical Supply chain Risk Assessment During COVID-19 Epidemic
The global health products supply chain is negatively influenced by the COVID-19 pandemic. Moreover, the risks in the pharmaceutical supply chain (PSC) have increased. Assessment and mitigation risks in PSC are essential issues to control and counter these risks. In this study, a 2-Tuple ARAS-BWM ap...
Autores principales: | BenAmor, W. Daoud, Labella, A., Frikha, H. Moalla, López, L. Martínez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
, IFAC (International Federation of Automatic Control) Hosting by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605720/ http://dx.doi.org/10.1016/j.ifacol.2022.10.035 |
Ejemplares similares
-
Pharmaceutical Supply Chain
por: Kuglin, Fred
Publicado: (2015) -
Pharmaceutical supply chain risks: a systematic review
por: Jaberidoost, Mona, et al.
Publicado: (2013) -
COVID-19 disruptions and Norwegian food and pharmaceutical supply chains: Insights into supply chain risk management, resilience, and reliability
por: Bø, Eirill, et al.
Publicado: (2023) -
Information flow in the pharmaceutical supply chain
por: Yousefi, Nazila, et al.
Publicado: (2015) -
Coordination of a Dual-Channel Pharmaceutical Supply Chain Based on the Susceptible-Infected-Susceptible Epidemic Model
por: Hou, Yanhong, et al.
Publicado: (2020)